Study unveils the GDF1 signaling pathway's role in mitigating the adverse effects of hearing loss on Alzheimer's disease, spotlighting potential avenues for therapeutic development.
By Vijay Kumar MalesuMar 20 2024Reviewed by Susha Cheriyedath, M.Sc. In a recent study published in the journal Nature Aging, researchers investigated how hearing loss intensifies cognitive decline through the embryonic growth/differentiation factor 1 signaling pathway, offering potential therapeutic insights for Alzheimer's disease .
About the study In the present study, the researchers utilized both wild-type C57BL/6J mice and amyloid precursor protein /presenilin 1 mice, the latter genetically modified to express mutations associated with AD, displaying Aβ deposits in the brain by around 6 to 7 months of age. These mice were bred, and their offspring were identified through polymerase chain reaction analysis of tail deoxyribonucleic acid , focusing on males aged 3 to 4 months.
The researchers precisely detailed the reagents and antibodies used, ensuring the specificity and reliability of their immunoblotting and immunostaining protocols. Techniques such as ribonucleic acid sequencing, cell culture, and various biochemical assays complemented the study, offering insights into the molecular pathways influenced by GDF1 expression and its potential protective effects against AD progression.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Study opens the door to earlier diagnosis and potential treatment for Alzheimer's diseaseA study might open the door to earlier diagnosis and a potential pathway toward slowing the progression of Alzheimer's disease. Researchers have discovered a special receptor on immune cells that can effectively bind and neutralize harmful 'beta proteins,' which are strongly associated with the disease.
Read more »
Study highlights potential of p-tau217 assays in Alzheimer's clinical trials and diagnosisThe performance of two commercial phospho-tau217 (p-tau217) assays.
Read more »
Nutrition and Alzheimer's disease may be linked, study findsMalnutrition may increase a person's chances of contracting Alzheimer's disease, which in turn exacerbates malnutrition. That's according to a March 2024 study out of China published in Frontiers in Nutrition.
Read more »
Wristwatch-like devices detect early signs of Alzheimer'sMonitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer's disease, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
Read more »
Nutrition's crucial role in Alzheimer's progression revealedStudy highlights the strong association between nutrition, particularly malnutrition, and the risk and progression of Alzheimer's disease, emphasizing early dietary interventions as key to reducing AD's global burden.
Read more »
FDA delays decision on new Alzheimer's drugInstead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's maker said Friday.
Read more »